Publications by authors named "Gillet D"

Post-traumatic stress disorder (PTSD) is a psychiatric condition triggered by experiencing or witnessing traumatic events, such as death, serious injury, or threats to oneself or others. Affecting 5-10 % of the population, PTSD is often underreported due to the reluctance of individuals to disclose personal traumatic experiences. This study explore the effectiveness of a digital (electronic mental health and psychosocial support) and psychologist-led intervention in mitigating PTSD symptoms.

View Article and Find Full Text PDF

Chitosans are promising biopolymers for diverse applications, with material properties and bioactivities depending i.a. on their pattern of acetylation (PA).

View Article and Find Full Text PDF

DABMA is a chemical molecule optimized from the parent compound ABMA and exhibits broad-spectrum antipathogenic activity by modulating the host's endolysosomal and autophagic pathways. Both DABMA and ABMA inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a cellular assay, which further expands their anti-pathogen spectrum in vitro. However, their precise mechanism of action has not yet been resolved.

View Article and Find Full Text PDF

Sterol-binding proteins are important regulators of lipid homeostasis and membrane integrity; however, the discovery of selective modulators can be challenging due to structural similarities in the sterol-binding domains. We report the discovery of potent and selective inhibitors of oxysterol-binding protein (OSBP), which we term oxybipins. Sterol-containing chemical chimeras aimed at identifying new sterol-binding proteins by targeted degradation, led to a significant reduction in levels of Golgi-associated proteins.

View Article and Find Full Text PDF

Human respiratory syncytial virus (hRSV) is the most common cause of bronchiolitis and pneumonia in newborns, with all children being infected before the age of two. Reinfections are very common throughout life and can cause severe respiratory infections in the elderly and immunocompromised adults. Although vaccines and preventive antibodies have recently been licensed for use in specific subpopulations of patients, there is still no therapeutic treatment commonly available for these infections.

View Article and Find Full Text PDF

Antileishmanial chemotherapy is currently limited due to severe toxic side effects and drug resistance. Hence, new antileishmanial compounds based on alternative approaches, mainly to avoid the emergence of drug resistance, are needed. The present work aims to decipher the mechanism of action of an antileishmanial drug candidate, named VP343, inhibiting intracellular survival via the host cell.

View Article and Find Full Text PDF
Article Synopsis
  • The concept of nursing consultation is particularly important for individuals experiencing chronic pain, highlighting the role of pain resource nurses (PRNs).
  • The French Society for the Study and Treatment of Pain has created a framework outlining the stages of managing chronic pain patients that PRNs can follow.
  • As healthcare needs evolve, the role of PRNs may develop into that of advanced practice nurses to better meet patient expectations.
View Article and Find Full Text PDF

Autophagy is a complex and highly regulated degradative process, which acts as a survival pathway in response to cellular stress, starvation and pathogen infection. Ricin toxin is a plant toxin produced by the castor bean and classified as a category B biothreat agent. Ricin toxin inhibits cellular protein synthesis by catalytically inactivating ribosomes, leading to cell death.

View Article and Find Full Text PDF
Article Synopsis
  • Plasma cells are crucial for immune function, but how they survive and secrete antibodies is not fully understood.
  • Researchers found that the protein Sec22b is vital for maintaining plasma cell function; without it, plasma cells are barely present and antibodies are significantly lower.
  • Sec22b helps in effective antibody secretion and maintains plasma cell health by regulating their gene activity and the structure of the endoplasmic reticulum and mitochondria.
View Article and Find Full Text PDF

A recently developed inhibitor of retrograde transport, namely Retro-2.1, proved to be a potent and broad-spectrum lead in vitro against intracellular pathogens, such as toxins, parasites, intracellular bacteria and viruses. To circumvent its low aqueous solubility, a formulation in poly(ethylene glycol)--poly(D,L)lactide micelle nanoparticles was developed.

View Article and Find Full Text PDF

The development of anti-infectives against a large range of AB-like toxin-producing bacteria includes the identification of compounds disrupting toxin transport through both the endolysosomal and retrograde pathways. Here, we performed a high-throughput screening of compounds blocking Rac1 proteasomal degradation triggered by the Cytotoxic Necrotizing Factor-1 (CNF1) toxin, which was followed by orthogonal screens against two toxins that hijack the endolysosomal (diphtheria toxin) or retrograde (Shiga-like toxin 1) pathways to intoxicate cells. This led to the identification of the molecule C910 that induces the enlargement of EEA1-positive early endosomes associated with sorting defects of CNF1 and Shiga toxins to their trafficking pathways.

View Article and Find Full Text PDF

Influenza virus is an acute and highly contagious respiratory pathogen that causes great concern to public health and for which there is a need for extensive drug discovery. The small chemical compound ABMA and its analog DABMA, containing an adamantane or a dimethyl-adamantane group, respectively, have been demonstrated to inhibit multiple toxins (diphtheria toxin, toxin B, lethal toxin) and viruses (Ebola, rabies virus, HSV-2) by acting on the host's vesicle trafficking. Here, we showed that ABMA and DABMA have antiviral effects against both amantadine-sensitive influenza virus subtypes (H1N1 and H3N2), amantadine-resistant subtypes (H3N2), and influenza B virus with EC values ranging from 2.

View Article and Find Full Text PDF
Article Synopsis
  • The study explored compounds targeting the host cell machinery to stop Leishmania parasite growth while reducing the risk of drug resistance.
  • The research focused on screening adamantamine derivatives to find a drug candidate effective against the intramacrophage form of Leishmania infantum.
  • VP343 was identified as a promising candidate, showing significant efficacy in vitro and in vivo, and favorable ADME properties for future drug development.*
View Article and Find Full Text PDF

This study evaluated the efficacy of the combined application of well-characterized chitosan polymer (degree of acetylation = 10%, degree of polymerization [DPn] = 90, and dispersity [Ð] = 2.8) and oligomers (partially acetylated chitosan polymers and oligosaccharides [paCOS]) (DP = 2 to 17) on conidia germination and mycelial growth of , the major causal agent of Fusarium head blight in wheat. The polymer alone showed a higher inhibitory effect than the paCOS mixture alone, with half-maximal inhibitory concentrations of less than 50 µg ml and more than 100 µg ml, respectively.

View Article and Find Full Text PDF

The data throughput of massive spectroscopic surveys in the course of each observation is directly coordinated with the number of optical fibers which reach their target. In this paper, we evaluate the safety and the performance of the astrobots coordination in SDSS-V by conducting various experimental and simulated tests. We illustrate that our strategy provides a complete coordination condition which depends on the operational characteristics of astrobots, their configurations, and their targets.

View Article and Find Full Text PDF

Designing and implementing online or digital learning material is a demanding task for teachers. This is even more the case when this material is used for more engaged forms of learning, such as inquiry learning. In this article, we give an informed account of Go-Lab, an ecosystem that supports teachers in creating Inquiry Learning Spaces (ILSs).

View Article and Find Full Text PDF

ABMA and its analogue DABMA are two molecules of the adamantane family known to perturbate the endosomal pathway and to inhibit cell infection of several RNA and DNA viruses. Their activity against Rabies Virus (RABV) infection has already been demonstrated in vitro. (Wu et al.

View Article and Find Full Text PDF

Shiga toxin (Stx)-stimulated blood cells shed extracellular vesicles (EVs) which can transfer the toxin to the kidneys and lead to hemolytic uremic syndrome. The toxin can be taken up by renal cells within EVs wherein the toxin is released, ultimately leading to cell death. The mechanism by which Stx is taken up, translocated, and sequestered in EVs was addressed in this study utilizing the B-subunit that binds to the globotriaosylceramide (Gb3) receptor.

View Article and Find Full Text PDF

High-throughput screening has shown that Retro-1 inhibits ricin and Shiga toxins by diminishing their intracellular trafficking via the retrograde route, from early endosomes to the Golgi apparatus. To improve the activity of Retro-1, a structure-activity relationship (SAR) study was undertaken and yielded an analogue with a roughly 70-fold better half-maximal effective concentration (EC) against Shiga toxin cytotoxicity measured in a cell protein synthesis assay.

View Article and Find Full Text PDF

Shiga toxin is the main virulence factor of non-invasive enterohemorrhagic strains capable of causing hemolytic uremic syndrome. Our group has previously shown that the toxin can reach the kidney within microvesicles where it is taken up by renal cells and the vesicles release their cargo intracellularly, leading to toxin-mediated inhibition of protein synthesis and cell death. The aim of this study was to examine if recipient cells must express the globotriaosylceramide (Gb3) toxin receptor for this to occur, or if Gb3-negative cells are also susceptible after uptake of Gb3-positive and toxin-positive microvesicles.

View Article and Find Full Text PDF

The retrograde transport inhibitor Retro-2 has a protective effect on cells and in mice against Shiga-like toxins and ricin. Retro-2 causes toxin accumulation in early endosomes and relocalization of the Golgi SNARE protein syntaxin-5 to the endoplasmic reticulum. The molecular mechanisms by which this is achieved remain unknown.

View Article and Find Full Text PDF

The ionophore lasalocid is widely used as a veterinary drug against coccidiosis. We found recently that lasalocid protects cells from two unrelated bacterial toxins, the cytotoxic necrotizing factor-1 (CNF1) from and diphtheria toxin. We evaluated lasalocid's capacity to protect cells against other toxins of medical interest comprising toxin B from , Shiga-like toxin 1 from enterohemorrhagic and exotoxin A from .

View Article and Find Full Text PDF
Article Synopsis
  • * ABMA, discovered through a screening for ricin toxin's cytotoxicity, shows wide-ranging antitoxin and antipathogen properties by retaining and delaying the trafficking of endocytosed proteins and toxins to late endosomes.
  • * Unlike other known inhibitors, ABMA specifically affects late endosomes and disrupts autophagic flux, making it both a potential therapeutic agent against toxins and pathogens, and a valuable tool for studying the endo-lysosomal system's role in cellular processes and disease mechanisms
View Article and Find Full Text PDF

The small molecule ABMA has been previously shown to protect cells against multiple toxins and pathogens including virus, intracellular bacteria, and parasite. Its mechanism of action is directly associated with host endolysosomal pathway rather than targeting toxin or pathogen itself. However, the relationship of its broad-spectrum anti-infection activity and chemical structure is not yet resolved.

View Article and Find Full Text PDF

Herpes simplex virus type 2 (HSV-2) infection has been a public health concern worldwide. It is the leading cause of genital herpes and a contributing factor to cervical cancer and human immunodeficiency virus (HIV) infection. No vaccine is available yet for the treatment of HSV-2 infection, and routinely used synthetic nucleoside analogs have led to the emergence of drug resistance.

View Article and Find Full Text PDF